Importance of margin extent as a predictor of outcome after adjuvant radiotherapy for Gleason score 7 pT3N0 prostate cancer

被引:13
|
作者
Valicenti, RK
Chervoneva, I
Gomella, LG
机构
[1] Thomas Jefferson Univ Hosp, Bodine Ctr Canc Treatment, Kimmel Canc Ctr, Dept Radiat Oncol, Philadelphia, PA 19107 USA
[2] Thomas Jefferson Univ Hosp, Jefferson Med Coll, Dept Radiat Oncol, Philadelphia, PA 19107 USA
[3] Thomas Jefferson Univ Hosp, Jefferson Med Coll, Dept Med, Philadelphia, PA 19107 USA
[4] Thomas Jefferson Univ Hosp, Jefferson Med Coll, Dept Urol, Philadelphia, PA 19107 USA
关键词
prostate cancer; Gleason score; surgical margins; radiotherapy;
D O I
10.1016/j.ijrobp.2003.07.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To evaluate, in Gleason score 7, pT3N0 prostate cancer patients with positive surgical margins, the predictors of progression-free survival and to identify a patient subgroup that would benefit from immediate adjuvant postoperative radiotherapy (ART). Methods and Materials: Between November 1989 and August 1998, 76 men underwent radical prostatectomy and were found to have capsular penetration (pT3N0), surgical Gleason score 7, tumor present at the resection margin, and an undetectable postoperative prostate-specific antigen (PSA) level. All surgical specimens underwent whole-mount serial sectioning to determine the degree of margin positivity (focal vs. extensive). Of the 76 men, 45 underwent early ART (within 6 months with a median dose of 64.8 Gy), and 31 had no immediate treatment. We defined freedom from PSA failure (bNED) as the absence of two consecutive PSA rises >0.2 ng/mL. Results: The median follow-up time was 5.1 years (range, 2-10 years). The ART and non-ART patients were similar with respect to preoperative PSA level, Gleason score (4 + 3 vs. 3 + 4), presence of seminal vesicle invasion, and margin extent. On univariate analysis, margin extent was predictive for improved bNED (5-year bNED rate of 92% vs. 58%, p = 0.010, for men with focal and extensive margins, respectively). Gleason score (4 + 3 vs. 3 + 4), seminal vesicle invasion, and ART were not statistically significant predictors. On multivariate analysis, the preoperative PSA level, margin extent, and ART were independent significant factors. In the group with extensive surgical margins, men receiving ART had a significantly greater 5-year bNED survival rate compared with the non-ART patients (73% vs. 31%, p = 0.004). Conclusion: These data suggest that the amount of microscopic residual tumor significantly affects bNED after radical prostatectomy for Gleason score 7, pT3N0 prostate cancer. In addition, men with pathologic evidence of microscopic local disease appear to benefit from early ART compared with untreated controls. (C) 2004 Elsevier Inc.
引用
收藏
页码:1093 / 1097
页数:5
相关论文
共 50 条
  • [1] Comparison of surgery alone with surgery and adjuvant radiotherapy for pT3N0 prostate cancer
    Petrovich, Z
    Lieskovsky, G
    Stein, JP
    Huberman, M
    Skinner, DG
    BJU INTERNATIONAL, 2002, 89 (06) : 604 - 611
  • [2] Postoperative radiotherapy in 423 patients with pT3N0 prostate cancer
    Petrovich, Z
    Lieskovsky, G
    Langholz, B
    Jozsef, G
    Streeter, OE
    Skinner, DG
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 53 (03): : 600 - 609
  • [3] Tumor location as an indication for adjuvant radiotherapy in pT3N0 rectal cancer after surgery
    Peng, Hai-hua
    Zhou, Xin-hui
    Zhou, Tong-chong
    Qiu, Xing-sheng
    You, Kai-yun
    RADIATION ONCOLOGY, 2019, 14 (1)
  • [4] Tumor location as an indication for adjuvant radiotherapy in pT3N0 rectal cancer after surgery
    Hai-hua Peng
    Xin-hui Zhou
    Tong-chong Zhou
    Xing-sheng Qiu
    Kai-yun You
    Radiation Oncology, 14
  • [5] Adjuvant radiotherapy in patients with pathologic stage C (pT3N0) adenocarcinoma of the prostate
    Petrovich, Z
    Lieskovsky, G
    Langholz, B
    Bochner, B
    Formenti, S
    Streeter, O
    Skinner, DG
    UROLOGY, 1999, 53 (06) : 1184 - 1193
  • [6] 10-year Results of Adjuvant Radiotherapy after Radical Prostatectomy in pT3N0 Prostate Cancer (EORTC 22911)
    Bolla, M.
    Van Poppel, H.
    Tombal, B.
    Vekemans, K.
    Da Pozzos, L.
    De Reijke, T. M.
    Verbaeys, A.
    Bosset, J. F.
    Van Velthoven, R.
    Collette, L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S29 - S29
  • [7] Quantification of high grade tumor is a predictor of disease progression in pT3N0 prostate cancer
    Herman, CM
    Kattan, MW
    Scardino, PT
    Wheeler, TM
    LABORATORY INVESTIGATION, 1999, 79 (01) : 97A - 97A
  • [8] In the era of total mesorectal excision: adjuvant radiotherapy may be unnecessary for pT3N0 rectal cancer
    Jun-xin Wu
    Yu Wang
    Na Chen
    Lu-chuan Chen
    Peng-gang Bai
    Jian-ji Pan
    Radiation Oncology, 9
  • [9] In the era of total mesorectal excision: adjuvant radiotherapy may be unnecessary for pT3N0 rectal cancer
    Wu, Jun-xin
    Wang, Yu
    Chen, Na
    Chen, Lu-chuan
    Bai, Peng-gang
    Pan, Jian-ji
    RADIATION ONCOLOGY, 2014, 9
  • [10] The efficacy of early adjuvant radiation therapy for pT3N0 prostate cancer: A matched-pair analysis
    Valicenti, RK
    Gomella, LG
    Ismail, M
    Strup, SE
    Mulholland, SG
    Dicker, AP
    Petersen, RO
    Newschaffer, CJ
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 45 (01): : 53 - 58